Sarah Joanne Williams, Principal Accounting Officer at AN2 Therapeutics, Inc. (ANTX), sold 327 shares at $1.06 ($347) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $347 ANTX by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |